Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Glycorex Transplantation ABNGM:GTAB B -8.75%61 Median PS Value is kr2.98 as of Aug. 05, 2026, which is 100% below its 10-year median of 0.67. GuruFocus rates NGM:GTAB B with a GF Score™ of 61/100 and a GF Value™ of kr1.81 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 278 Biotechnology companies, Glycorex Transplantation AB ranks better than 62.95% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Glycorex Transplantation AB's Median PS Value or its related term are showing as below:
NGM:GTAB B'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.34 Med: 0.67 Max: 1.35
Current: 0.49
During the past 13 years, the highest Price to Median PS Value of Glycorex Transplantation AB was 1.35. The lowest was 0.34. And the median was 0.67.
NGM:GTAB B's Price-to-Median-PS-Value is ranked better than 62.95% of 278
companies
in the Biotechnology industry
Industry Median: 0.625
vs NGM:GTAB B: 0.49
Glycorex Transplantation AB (NGM:GTAB B) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Glycorex Transplantation AB's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
1.46
/
2.98
=
0.49
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glycorex Transplantation AB Median PS Value Related Terms
Glycorex Transplantation AB Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGM:GTAB B vs VRTX, REGN, RVMD: Median PS Value Comparison
For the Biotechnology subindustry, Glycorex Transplantation AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glycorex Transplantation AB Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Glycorex Transplantation AB's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Glycorex Transplantation AB's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 6.0941.
Glycorex Transplantation AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.489.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glycorex Transplantation AB (NGM:GTAB B) has a Median PS Value of kr2.98 as of Aug. 05, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Glycorex Transplantation AB and its competitors. This is 345% above median its historical median of 0.67. Over the past decade, Glycorex Transplantation AB's Median PS Value has ranged from 0.34 to 1.35. According to the industry distribution chart, Glycorex Transplantation AB ranks #103 out of 278 companies in the Biotechnology industry, placing it in the top 37.1%.
Is Glycorex Transplantation AB's Median PS Value too high?
Glycorex Transplantation AB's current Median PS Value of kr2.98 is 345% above median its 10-year median of 0.67. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 1.35. Based on the distribution chart, Glycorex Transplantation AB ranks #103 out of 278 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Glycorex Transplantation AB has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Glycorex Transplantation AB's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Glycorex Transplantation AB ranks #103 out of 278 companies for Median PS Value. This puts Glycorex Transplantation AB in the upper half of its industry. The industry median Median PS Value is 0.63. Historically, Glycorex Transplantation AB's own Median PS Value has ranged from 0.34 to 1.35 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 278 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Glycorex Transplantation AB and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glycorex Transplantation AB's current Median PS Value is kr2.98, which is 345% above median its own 10-year median of 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glycorex Transplantation AB stock overvalued right now?
Based on GuruFocus' analysis, Glycorex Transplantation AB (NGM:GTAB B) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.81, compared to a current price of kr1.46 — trading 19.3% below its estimated fair value. The current Median PS Value is kr2.98, which is 345% above median its 10-year median of 0.67. Glycorex Transplantation AB's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Glycorex Transplantation AB (NGM:GTAB B), the current Median PS Value is kr2.98 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glycorex Transplantation AB (NGM:GTAB B) Overvalued in 2026?
Based on GuruFocus' analysis, Glycorex Transplantation AB stock appears to be undervalued.
The current stock price of kr1.46 is trading 19.3% below its estimated GF Value™ of kr1.81.
GuruFocus considers Glycorex Transplantation AB to be Modestly Undervalued.
Key valuation signals for NGM:GTAB B:
Median PS Value: kr2.98 (345% above median its 10-year median of 0.67)
GF Value™: kr1.81 vs. price of kr1.46 (19.3% below fair value)
No single metric tells the full story. See the NGM:GTAB B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glycorex Transplantation AB is a medical technology company. Its main product Glycosorb ABO is used clinically in six continents to facilitate blood group incompatible transplants, especially in kidney transplants from related living donors, but also in transplantation of liver, heart, lung and stem cells. Glycosorb ABO enables grafts regardless of the blood group of donors and recipients. The product is used in extracorporeal blood treatment, that is, a blood treatment that takes place outside the body in the same way as dialysis. Its segment is research, develop, manufacture, market and sell products in the field of organ transplantation or related areas. Geographically it operates in Europe, Australia, Singapore, India, and Other countries with majority of revenue from Europe.
61GF Score
Get the complete analysis for NGM:GTAB B
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:GTAB B has been successfully added to your 
